Critical Outcome Tec (COTQF) 0.2300 $COTQF Critical

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Critical Outcome Tec (COTQF) 0.2300 $COTQF

Critical Outcome Technologies Strengthens Its Board
Marketwired - Thu May 14, 7:30AM CDT
Critical Outcome Technologies Inc. ("COTI" or the "Company" (TSX VENTURE: COT)(OTCQB: COTQF) is very pleased to announce that Ms. Alison Silva has been appointed to the Board of Directors ("Board" of the Company as an independent director, subject to final regulatory approval.
COT.VN: 0.270 (-0.010)

HIV-1 Infection - Pipeline Review, H1 2015
M2 - Wed May 13, 5:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wrjl97/hiv1_infection) has announced the addition of the "HIV-1 Infection - Pipeline Review, H1 2015" report to their offering. This report provides comprehensive information on the therapeutic development for HIV-1 Infection, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for HIV-1 Infection and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - AlphaVax, Inc. - AltraVax Inc. - Aphios Corporation - Argos Therapeutics, Inc. - Bionor Pharma ASA - Biosantech SA - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Company - CompleGen, Inc. - Critical Outcome Technologies Inc. - CytoDyn Inc. - Enzo Biochem, Inc. - FIT Biotech Oy - GeneCure LLC - Gilead Sciences, Inc. - GlaxoSmithKline plc - Heat Biologics, Inc. - InnaVirVax SA - Inovio Pharmaceuticals, Inc. - Johnson & Johnson - Merck & Co., Inc. - Mymetics Corporation - Myrexis, Inc. - Oncovir, Inc. - OyaGen Inc. - Peregrine Pharmaceuticals, Inc. - Pfizer Inc. - Pharis Biotec GmbH - United Biomedical, Inc. - Valens Therapeutics, Inc. - Vichem Chemie Research Ltd. - ViiV Healthcare Limited For more information visit http://www.researchandmarkets.com/research/wr..._infection
HTBX: 5.77 (-0.40), PFE: 33.99 (+0.05), BMY: 67.64 (+0.19), GSK: 44.77 (-0.22), ARGS: 7.68 (+0.09), INO: 7.97 (-0.02), JNJ: 102.30 (+0.47), ENZ: 2.50 (unch), GILD: 109.30 (+0.56), MRK: 60.23 (+0.45)

Critical Outcome Technologies Adds First European Patent to Growing Intellectual Property Protection for COTI-2
Marketwired - Mon May 11, 7:31AM CDT
Critical Outcome Technologies Inc. ("COTI" or the "Company" (TSX VENTURE: COT)(OTCQB: COTQF) announced today that the European Patent Office has granted the Company European Patent No. 2121681 for its lead cancer drug candidate, COTI-2. This patent covers the composition of matter of COTI-2, the Company's small molecule activator of misfolded mutant p53 protein. Issuance of this European patent provides the Company with additional protection and licensing opportunities for the COTI-2 franchise in European markets.
COT.VN: 0.270 (-0.010)

Critical Outcome Technologies Files Investigational New Drug Application With the FDA for COTI-2
Marketwired - Mon Apr 27, 7:31AM CDT
Critical Outcome Technologies Inc. ("COTI" or the "Company" (TSX VENTURE: COT) (OTCQB: COTQF), announced today the filing of an Investigational New Drug ("IND" application with the U.S. Food and Drug Administration's Center for Drug Evaluation and Research ("FDA" for COTI-2, a potential breakthrough therapy intended for the treatment of women with gynecological cancers with p53 mutations. Advanced gynecological cancers have a particularly high prevalence rate (as high as 95%) of p53 mutations. The IND application is a complete description of the chemistry, non-clinical pharmacodynamics and pharmacokinetics, safety toxicology, manufacturing and other relevant information related to COTI-2 as a potential treatment for patients with p53 mutations.
COT.VN: 0.270 (-0.010)

Critical Outcome Technologies Receives First U.S. Patent for Next Generation HIV Treatment
Marketwired - Wed Apr 15, 7:30AM CDT
Critical Outcome Technologies Inc. ("COTI" or the "Company" (TSX VENTURE: COT) (OTCQB: COTQF) announced today that it has been granted a U.S. patent for the Company's novel HIV integrase inhibitor compounds.
COT.VN: 0.270 (-0.010)

Critical Outcome Technologies Inc. Strengthens Its Investor Relations Outreach
Marketwired - Thu Apr 02, 8:01AM CDT
Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Company" announced today it has retained Stonegate Capital Partners, Inc. ("Stonegate" to provide strategic investor relations services on behalf of the Company in the United States with a specific focus on the U.S. small-cap life science institutional investment community. Stonegate is a Dallas-based consulting firm providing a full range of services to help a select group of public company clients build awareness, manage investor expectations, and broaden and strengthen investor relationships with a strong focus on institutional investors.
COT.VN: 0.270 (-0.010)

Critical Outcome Technologies Establishes Advisory Board for the Clinical Development of COTI-2
Marketwired - Mon Mar 23, 7:30AM CDT
Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Company" announced today the formation of a Scientific Advisory Board ("SAB" to support the clinical development of its lead cancer drug candidate, COTI-2. Appointed to the Scientific Advisory Board are Dr. Gordon Mills from the University of Texas MD Anderson Cancer Center, Houston, TX, Dr. Douglas Levine from the Memorial Sloan-Kettering Cancer Center in New York City, NY, Dr. David Parkinson from New Enterprise Associates in Menlo Park, CA, and Dr. Marshall Strome from the Center for Head and Neck Oncology at Mount Sinai-Roosevelt Hospital in New York City, NY. The Company also announced that Ashley ten Haaf has joined the Company as its Clinical Trials Manager, responsible for the planning, execution and reporting of clinical trials pursued by the Company.
COT.VN: 0.270 (-0.010)

Critical Outcome Technologies Reports Fiscal 2015 Third Quarter Results
Marketwired - Fri Mar 20, 3:05PM CDT
Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Company" reported its financial and operating results for the three and nine month periods ended January 31, 2015.
COT.VN: 0.270 (-0.010)

Critical Outcome Provides Update on COTI-2 IND Filing
Marketwired - Mon Mar 02, 8:33AM CST
Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Corporation" provides an update with respect to the status of its planned IND filing with the United States Food and Drug Administration that supports a Phase 1 clinical study for its lead oncology drug candidate, COTI-2, in gynecological cancers.
COT.VN: 0.270 (-0.010)

Critical Outcome Technologies Closes Private Placement
Marketwired - Wed Feb 18, 7:30AM CST
Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Corporation" announced the closing of a non-brokered private placement of 2,129,374 units (the "Units" at a price of CAD $0.255 per Unit for gross proceeds of approximately $543,000.
COT.VN: 0.270 (-0.010)

Critical Outcome Technologies Planning Phase 1 Clinical Trial of COTI-2 in Recurrent Head and Neck Cancers
Marketwired - Tue Jan 20, 8:05AM CST
Critical Outcome Technologies Inc. ("COTI" or the "Company" (TSX VENTURE: COT) (OTCQB: COTQF), the biopharmaceutical company that uses machine learning to rapidly develop targeted therapies, announced today that it has executed a material transfer agreement ("MTA" with Dr. John Yoo, MD, FRCSC, FACS, and his team at the London Health Sciences Centre's London Regional Cancer Program and Western University, for the continued evaluation of COTI-2 for the treatment of patients with recurrent head and neck squamous cell cancer ("HNSCC" .
COT.VN: 0.270 (-0.010)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Saint Luis Rey Launches Exclusive Palatinos Vitola

Updated Category News Views 89

New Beginnings for the Saint Luis Rey Brand You think you've seen it all in the cigar world, but then comes a debut like this that lights a fire under the lush tradition of Cuba. Enter Saint Luis Rey's new Palatinos vitola, a blend wrapped in the mystique of exclusivity for La Casa del Habano and Habanos Specialists. Whether you're a seasoned connoisseur or just dipping...

Continue Reading
Fold Health's AI: Revolutionizing Patient Care Dynamics

Updated Category News Views 85

AI's Role in Healthcare: From Insight to Action Healthcare's got a resource issue, plain and simple. It's like trying to fill a bathtub with a hole in it—clinicians are swamped, burnout is high, and patients aren't getting the attention they need. Enter Fold Health's AI operating layer, launched with the ambition to realign the equation. Not Just Another Tech Buzzword...

Continue Reading
Ave7® Pioneers AI-Driven Marketplace Evolution

Updated Category News Views 47

AI Reshapes the Agency Paradigm Nobody saw this coming a decade ago, but here we are—AI's taking the wheel, but with humans still riding shotgun. The agency world, particularly the one dealing with e-commerce giants like Amazon, Walmart, and Target, has flipped on its head. Ave7® steps up as the frontrunner, adapting faster than a broker's reflex after a market bell....

Continue Reading
A&G Management's Bold New Era with WPM Partnership

Updated Category News Views 134

Shaking Up Baltimore's Real Estate Scene Swapping up management partners can be a dicey game, but A&G Management seems to be pulling it off without a hitch. As of January 4, 2027, WPM Real Estate Management will take over the reins for more than 3,000 apartment homes scattered across Anne Arundel, Howard, and Baltimore counties. A new set of hands is stepping in for...

Continue Reading
PEGATRON Unveils AI and HPC Advances at SC26

Updated Category News Views 96

Revamping AI with High-Density Computing You know, back in the day, AI was just about training models and running basic inference. But now, it's all about these crazy agentic AI tasks—autonomous agents doing things I couldn't have imagined. PEGATRON's Evolution in Infrastructure PEGATRON's latest move at SC26 is a real leap forward in this ongoing AI saga. They're...

Continue Reading
IP Lawyer Chris Henry Returns to Latham: A Game Changer

Updated Category News Views 122

Welcome Home, Chris Henry! Folks, here's a headline that's making waves in the IP litigation water: Chris Henry has returned to Latham & Watkins, taking his place as a heavyweight partner in their Boston office. Now, if you're not deeply entangled in the world of high-stakes intellectual property (IP) disputes, you might shrug. But for tech companies embroiled in patent...

Continue Reading
Cardio Partners Hits a Million Milestone with Red Cross

Updated Category News Views 57

One Million Trained, One Million Prepared Ah, a million sounds like just another number, doesn't it? But when someone's life hangs in the balance, those are a million folks ready to jump in and act. Cardio Partners has hit this mighty milestone in CPR, AED, and First Aid training, gaining a pat on the back from none other than the American Red Cross. It's a testament,...

Continue Reading
RBC Grabs Top Honors for Sustainable Investing Leadership

Updated Category News Views 115

A New Feather in RBC's Cap RBC Wealth Management has racked up more accolades, crowned as the Best Private Bank in Canada and celebrated for its prowess in impact and sustainable investing on the global stage. These distinctions flew in courtesy of the PWM Global Private Banking Awards—a heavyweight recognition in the wealth management world. Award Winning Strategy in...

Continue Reading
Gwen Stefani Kicks Off OCVIBE's New Concert Hall

Updated Category News Views 217

A Homecoming Steeped in Nostalgia Orange County’s about to do a serious throwback, folks! Gwen Stefani is set to headline the opening concert at OCVIBE's spanking new concert hall in Anaheim on March 17, 2027. Curious choice for their opener? Hardly. This gal's practically woven into the county’s tapestry—her roots run deep here, enough to make even the casual music...

Continue Reading
AI Pushes Asset Managers Towards New Investment Growth

Updated Category News Views 102

AI: A Double-Edged Sword for Asset Managers Peeled straight from the heart of New York's financial buzz, AI is changing the game for asset and wealth managers. Now, we ain’t talking about some futuristic sci-fi scene, but real-world shifts that are scratching their way into boardrooms. Nearly 80% of firms playing the AI card see a sweet lift in productivity and...

Continue Reading

Top 5 Most Recently Viewed Articles

Mining Stocks: Resilience Amid Market Fluctuations and Trends

Updated Category News Views 466

Understanding the Mining Stocks' Performance In recent discussions, subscribers to the Mining Stock Journal have raised an intriguing question: Will a significant decline in the broader market be necessary for mining stocks to continue their upward trajectory? This line of thought seems to resonate with several market analysts, but it warrants a closer look. Mining stocks...

Continue Reading
Goliath Resources Unveils Ambitious 40,000-Meter Drill Campaign

Updated Category News Views 191

Exciting Times for Goliath Resources Goliath Resources is embarking on a groundbreaking journey with its largest drill campaign yet, focusing entirely on the high-grade gold discovery known as Surebet. This campaign aims to cover an impressive 40,000 meters and will utilize nine drilling rigs. The motivation for such an extensive drilling program stems from the...

Continue Reading
Who Will Dominate the Semiconductor Sector in 2024?

Updated Category News Views 137

The Competitive Landscape of Semiconductors The semiconductor industry is currently experiencing fierce competition, with three key players at the forefront: Broadcom Inc (NASDAQ: AVGO), Micron Technology Inc (NASDAQ: MU), and Marvell Technology Inc (NASDAQ: MRVL). By examining the specific strengths and hurdles each company faces, investors can gain valuable insights...

Continue Reading
Goldman Sachs' Recent Options Activity Shows Enthusiasm

Updated Category News Views 228

The Bullish Sentiment Surrounding Goldman Sachs In recent times, major financial players have shown a notable bullish sentiment towards Goldman Sachs Gr (NASDAQ: GS). Our analysis of the options market reveals intriguing insights through 37 distinctive trades surrounding this financial powerhouse. When we look deeper into the trading data, it's noteworthy that...

Continue Reading
Eramet's Strategies for Enhanced Operational Efficiency in 2025

Updated Category News Views 305

Analyzing Eramet's Strategic Direction in 2025 Eramet's commitment to operational efficiency has never been more critical than in 2025, especially after encountering significant pressures during the first half of the year. The company's recent announcements underscore an enhancement in various operational protocols, demonstrating a resilient approach towards addressing...

Continue Reading